Page last updated: 2024-09-03

zami 1327 and alprenolol

zami 1327 has been researched along with alprenolol in 1 studies

Compound Research Comparison

Studies
(zami 1327)
Trials
(zami 1327)
Recent Studies (post-2010)
(zami 1327)
Studies
(alprenolol)
Trials
(alprenolol)
Recent Studies (post-2010) (alprenolol)
7001,14612159

Protein Interaction Comparison

ProteinTaxonomyzami 1327 (IC50)alprenolol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.0031
Beta-1 adrenergic receptorHomo sapiens (human)0.007
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.63
Beta-3 adrenergic receptorHomo sapiens (human)0.0023
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0049
Squalene synthaseRattus norvegicus (Norway rat)4.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fishbein, L; Jackson, CD1

Reviews

1 review(s) available for zami 1327 and alprenolol

ArticleYear
A toxicological review of beta-adrenergic blockers.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1986, Volume: 6, Issue:3

    Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol

1986